Home › Pancreatic Cancer › Washington › Spokane
Pancreatic Cancer clinical trials in Spokane, WA
4 studies for Pancreatic Cancer are looking for participants at sites in and around Spokane (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RecruitingObservational study
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RecruitingPhase 3
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RecruitingPhase 2
- Ohio State University Telemedicine, Spokane
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
RecruitingPhase 2/3
- Medical Oncology Associates - Spokane, Spokane
About Pancreatic Cancer
The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.
More about Pancreatic Cancer on MedlinePlus
Pancreatic Cancer trials in other cities
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- San Antonio, TX31 studies
- Baltimore, MD31 studies
- Tampa, FL26 studies
- Philadelphia, PA26 studies
- San Diego, CA24 studies
Other studies in Spokane
- Non-Small Cell Lung Cancer12 studies
- Breast Cancer8 studies
- Ovarian Cancer8 studies
- Colorectal Cancer8 studies
- Parkinson's Disease7 studies
- Prostate Cancer6 studies
- Chronic Lymphocytic Leukemia6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Cancer (all types)6 studies
- Triple-Negative Breast Cancer5 studies
- Melanoma5 studies
- Macular Degeneration5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.